Items where authors include "Kemp, S.A."

Article

Ghafari, M. orcid.org/0000-0002-4123-3287, Hall, M. orcid.org/0000-0002-2671-3864, Golubchik, T. orcid.org/0000-0003-2765-9828 et al. (30 more authors) (2024) Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature, 626 (8001). pp. 1094-1101. ISSN 0028-0836

Meng, B., Abdullahi, A., Ferreira, I.A.T.M. et al. (219 more authors) (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603 (7902). pp. 706-714. ISSN 0028-0836

Mlcochova, P., Kemp, S.A., Dhar, M.S. et al. (258 more authors) (2021) SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 599. pp. 114-119. ISSN 0028-0836

Collier, D.A., De Marco, A., Ferreira, I.A.T.M. et al. (38 more authors) (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 593 (7857). pp. 136-141. ISSN 0028-0836

Kemp, S.A., Collier, D.A., Datir, R.P. et al. (34 more authors) (2021) SARS-CoV-2 evolution during treatment of chronic infection. Nature, 592 (7853). pp. 277-282. ISSN 0028-0836